Shoreline Biosciences, Inc. — Form D
Shoreline Biosciences, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-16. The offering totals $43.0M, of which $43.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-16
- Form: D
- Accession: 0001818870-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $43.0M
- Amount sold: $43.0M
- Investors: 20
- Date of first sale: 2021-01-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389545
Issuer
- Name: Shoreline Biosciences, Inc.
- CIK: 0001818870
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 11408 Sorrento Valley Road, San Diego, CA, 92121
- Phone: 858-247-7033
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Kleanthis G Xanthopoulos, Ph.D. | Director | San Diego, CA |
| Kleanthis G Xanthopoulos, Ph.D. | Executive Officer | San Diego, CA |
| Vanessa S Jacoby | Executive Officer | San Diego, CA |
| William S Sandborn | Executive Officer | San Diego, CA |
| Kimberly S Manhard | Director | San Diego, CA |
| Scott S Forrest | Executive Officer | San Diego, CA |
| Fan S Yu | Director | San Diego, CA |
| Marios G Fotiadis | Director | San Diego, CA |
| Steven G Holtzman | Director | San Diego, CA |
| Christopher S Fuglesang | Director | San Diego, CA |
| Kleanthis G Xanthopoulos | Director | San Diego, CA |
| Kleanthis G Xanthopoulos | Executive Officer | San Diego, CA |
| Dan S Kaufman | Director | San Diego, CA |
Other filings by this issuer (2)
More